KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Deferred Taxes: 2012-2025

Historic Deferred Taxes for Opko Health (OPK) over the last 11 years, with Sep 2025 value amounting to $18.3 million.

  • Opko Health's Deferred Taxes rose 50.24% to $18.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year increase of 1583.71%. This contributed to the annual value of $21.5 million for FY2024, which is 14650.68% up from last year.
  • Latest data reveals that Opko Health reported Deferred Taxes of $18.3 million as of Q3 2025, which was up 216.38% from -$15.7 million recorded in Q2 2025.
  • Opko Health's 5-year Deferred Taxes high stood at $18.3 million for Q3 2025, and its period low was -$39.9 million during Q3 2022.
  • Moreover, its 3-year median value for Deferred Taxes was $102,000 (2023), whereas its average is $1.5 million.
  • Its Deferred Taxes has fluctuated over the past 5 years, first soared by 746.27% in 2021, then tumbled by 39,445.54% in 2022.
  • Opko Health's Deferred Taxes (Quarterly) stood at $8.5 million in 2021, then slumped by 399.45% to -$25.5 million in 2022, then soared by 71.94% to -$7.2 million in 2023, then soared by 293.28% to $13.8 million in 2024, then surged by 50.24% to $18.3 million in 2025.
  • Its Deferred Taxes stands at $18.3 million for Q3 2025, versus -$15.7 million for Q2 2025 and -$7.4 million for Q1 2025.